US20230047698A1 - Expansion sock - Google Patents
Expansion sock Download PDFInfo
- Publication number
- US20230047698A1 US20230047698A1 US17/969,353 US202217969353A US2023047698A1 US 20230047698 A1 US20230047698 A1 US 20230047698A1 US 202217969353 A US202217969353 A US 202217969353A US 2023047698 A1 US2023047698 A1 US 2023047698A1
- Authority
- US
- United States
- Prior art keywords
- sock
- foot
- section
- calf portion
- calf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004744 fabric Substances 0.000 claims abstract description 88
- 239000000463 material Substances 0.000 claims abstract description 49
- 210000002683 foot Anatomy 0.000 claims description 113
- 244000309466 calf Species 0.000 claims description 70
- 210000004744 fore-foot Anatomy 0.000 claims description 31
- 210000000452 mid-foot Anatomy 0.000 claims description 18
- 230000006835 compression Effects 0.000 claims description 8
- 238000007906 compression Methods 0.000 claims description 8
- 210000003371 toe Anatomy 0.000 claims description 7
- 230000000845 anti-microbial effect Effects 0.000 claims description 6
- 239000002783 friction material Substances 0.000 claims description 6
- 210000001872 metatarsal bone Anatomy 0.000 claims description 6
- 239000012782 phase change material Substances 0.000 claims description 6
- 239000011810 insulating material Substances 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 5
- 210000002268 wool Anatomy 0.000 claims description 5
- 229920002334 Spandex Polymers 0.000 claims description 4
- -1 copper metals Chemical class 0.000 claims description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- 239000004759 spandex Substances 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 2
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 2
- 229920000297 Rayon Polymers 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004809 Teflon Substances 0.000 claims description 2
- 229920006362 Teflon® Polymers 0.000 claims description 2
- 150000003868 ammonium compounds Chemical class 0.000 claims description 2
- 239000011425 bamboo Substances 0.000 claims description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 2
- 239000003139 biocide Substances 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 239000000417 fungicide Substances 0.000 claims description 2
- 229910001385 heavy metal Inorganic materials 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 150000002989 phenols Chemical class 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000002964 rayon Substances 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 2
- 241001330002 Bambuseae Species 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 208000017899 Foot injury Diseases 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 208000034657 Convalescence Diseases 0.000 description 7
- 208000014674 injury Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 4
- 230000003100 immobilizing effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000000399 orthopedic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 206010061225 Limb injury Diseases 0.000 description 2
- 241001272996 Polyphylla fullo Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000001266 bandaging Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000001255 hallux Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- 206010006585 Bunion Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 208000031074 Reinjury Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B11/00—Hosiery; Panti-hose
- A41B11/003—Hosiery with intermediate sections of different elasticity
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B2400/00—Functions or special features of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
- A41B2400/34—Functions or special features of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass antimicrobial or antibacterial
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B2400/00—Functions or special features of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
- A41B2400/60—Moisture handling or wicking function
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B2500/00—Materials for shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
- A41B2500/10—Knitted
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D2400/00—Functions or special features of garments
- A41D2400/32—Therapeutic use
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D2500/00—Materials for garments
- A41D2500/10—Knitted
Definitions
- This disclosure relates to socks, and in particular, to an expansion sock for use by patients having a bandaged foot.
- Neither traditional socks nor compression socks are suitable to accommodate the needs or address the challenges of appropriately accommodating a bandaged foot having increased dimension compared to a non-bandaged one.
- a traditional sock large enough to accommodate the expanded foot bandage may gather, crease, or otherwise form discontinuities adjacent the bandage, or may not fit the patient's calf.
- Compression socks generally constrict the foot portion more than the calf portion and thus constrict the bandaged foot area. Accordingly, it would be beneficial to address the foregoing challenges, drawbacks and disadvantages.
- the expansion sock of the present disclosure may have knitted fabric which comprises materials exhibiting one or more of the foregoing properties.
- the expansion sock may include padded fabric at various locations to aid in convalescence, protection or comfort or combinations of any of the foregoing.
- padding may be provided in the forefoot region to deal with metatarsal surgery, injury, support, or other medical conditions, or convalescence from associated medical procedures.
- orthopedic or other medical conditions, wounds, ulcers, and the like afflicting the heel may be addressed by suitable padding, and injuries to the calf, especially to the shin area, may be addressed by padded portions located on the expansion sock to correspond to the antibial crest when worn by the patient.
- FIG. 1 is an isometric view showing one implementation of an expansion sock according to the present disclosure worn by a patient with a bandaged foot in a suitable mobilizing or therapeutic device;
- Expansion sock 121 includes calf portion 123 sized and configured to fit over an unbandaged calf of a patient, and foot portion 127 is configured to fit over a bandaged foot, the portions 123 , 127 adjoining each other at opposing, respective bottom and top edges 125 , 129 .
Abstract
An expansion sock includes one or more expansion zones formed of a different type of knitted fabric than adjacent zones. The expansion zones permit the sock to be used on a person's bandaged foot because the bandaged portions of the foot can be accommodated without either increased pressure on the bandages while minimizing excess, bunched material adjacent thereto.
Description
- The present application is a continuation of U.S. application Ser. No. 17/066,437 filed on Oct. 8, 2020, which is a continuation of U.S. application Ser. No. 15/821,273 filed on Nov. 22, 2017 and claims priority to U.S. application Ser. No. 15/821,273.
- This disclosure relates to socks, and in particular, to an expansion sock for use by patients having a bandaged foot.
- A person's foot may undergo any number of injuries, sprains, wounds, or other disorders and afflictions, whether caused by direct accident, or as secondary effects of other trauma, heart conditions, blood conditions, diabetes, or any number of other medical conditions (collectively referred to herein as “foot injuries”). When people with foot injuries become patients under the care of medical practitioners, there are any number of treatments which the patient's foot may undergo. Such treatments may include, without limitation, surgical procedures, such as to correct bunions, orthopedic or other foot conditions, tissue or bone repair procedures, wound or ulcer treatment, and the like, or medical procedures may involve bracing or other supportive and corrective orthoses.
- Inevitably, treatment of foot injuries may involve bandaging all or portions of the foot, whether for short or extended periods of time. Treatment of foot injuries generally involves bandages beyond the mere surface application of an adhesive bandage that substantially remains within the planar contours of the foot. Bandages for foot injuries may instead involve multiple layers, often with gauze, casting material and the like, and thereby the bandaged foot assumes a profile which extends beyond the normal outer surfaces of a healthy or unbandaged foot. Feet recovering from treatments or from foot injuries may also assume an expanded profile by mere swelling alone.
- Generally, during treatment or convalescence, the bandaged foot needs to be placed either in any number of immobilizing devices, such as boots, cam walkers, casts, splints, surgical shoe, and other limb orthoses, or in suitable footwear, depending on the nature of the foot injury.
- The increased dimensions of the bandaged foot, as opposed to its normal profile, pose challenges to covering the foot (including the toes) with a sock, when such sock coverage is necessary or desirable.
- Frequently, the patient winds up having exposed portions of the foot during convalescence or treatment, even when such foot is received in a suitable walker, brace, or other convalescent or therapeutic footwear, not to mention the challenges of such bandaged foot being placed in a regular shoe.
- There are numerous drawbacks and disadvantages to having portions of the foot uncovered by a suitable sock, ranging not only from exposure to the elements, but also including potential for a re-injury of the foot, or even injured self-esteem as the exposed foot may be visible to the public. In a similar vein, enclosing the bandaged foot with a suitable sock often aids in healing and convalescence, improved self-esteem, and may keep the foot from excess cold or heat. Suitable enclosure of the bandaged foot may isolate the foot from microbes, bacteria or infectious agents, as well as adding to comfort, in that exposed portions of the foot or the bandage itself do not experience uncomfortable pressure from the brace, boot or other immobilizing device potentially associated with convalescence.
- Neither traditional socks nor compression socks are suitable to accommodate the needs or address the challenges of appropriately accommodating a bandaged foot having increased dimension compared to a non-bandaged one. A traditional sock large enough to accommodate the expanded foot bandage may gather, crease, or otherwise form discontinuities adjacent the bandage, or may not fit the patient's calf. Compression socks generally constrict the foot portion more than the calf portion and thus constrict the bandaged foot area. Accordingly, it would be beneficial to address the foregoing challenges, drawbacks and disadvantages.
- In one possible implementation, an expansion sock for use with a bandaged foot has a calf portion which goes around the leg of the patient and extends down to join with a foot portion which is sized and shaped to enclose the foot of the patient. For purposes of this disclosure, the foot portion can be conceptually divided into a heel-ankle section, a mid-foot section, and a forefoot section. For the sock to fit the patient's calf, the calf portion is configured to have knitted material that generates a comfortable amount of compressive force, less than 20 mmHg when the calf portion is expanded stretching by about 15% in volume from its relaxed state.
- Furthermore, according to this disclosure, one or more parts of the foot portion have a second type of knitted fabric which is more expandable than the fabric in the calf portion. By “more expandable” it is meant that, in one possible implementation, the fabric in the foot portion defines an expansion zone and it is able to maintain a compressive force of less than 20 mmHg, even when the expansion zone is required to stretch beyond 15% of the volume of the foot portion in the relaxed state, such as when accommodating a bandage in such foot portion.
- In other implementations, the fabric of the foot portion can generate less than 20 mmHg of compressive force even when the expansion zone is expanded to a volume ranging between 50% and 200% of the volume of the relaxed state.
- In various implementations, the knitted fabric which expands more easily to form the expansion zone may be located in the heel-ankle section, the mid-foot section, the forefoot section, or any combination of the foregoing. The location of the expansion zones may be adapted to anticipated uses with patients suffering from particular types of bandaged feet.
- Certain foot injuries may benefit from avoiding excess friction between overlying portions of the sock material, may also benefit from having the sock material be anti-microbial, insulative, or having enhanced wicking properties to reduce foot perspiration. Accordingly, in various implementations, the expansion sock of the present disclosure may have knitted fabric which comprises materials exhibiting one or more of the foregoing properties.
- In still further implementations, the expansion sock may include padded fabric at various locations to aid in convalescence, protection or comfort or combinations of any of the foregoing. For example, padding may be provided in the forefoot region to deal with metatarsal surgery, injury, support, or other medical conditions, or convalescence from associated medical procedures. Similarly, orthopedic or other medical conditions, wounds, ulcers, and the like afflicting the heel may be addressed by suitable padding, and injuries to the calf, especially to the shin area, may be addressed by padded portions located on the expansion sock to correspond to the antibial crest when worn by the patient.
- These and other features of the foregoing inventions are further appreciated by reference to the following drawings, in which:
-
FIG. 1 is an isometric view showing one implementation of an expansion sock according to the present disclosure worn by a patient with a bandaged foot in a suitable mobilizing or therapeutic device; -
FIG. 2 is a side elevational view of another possible implementation of the present disclosure of an expansion sock; -
FIGS. 3 and 4 are front- and rear-elevational views of the implementation shown inFIG. 2 ; -
FIGS. 5 and 6 are front- and side-elevational views of another possible implementation of an expansion sock according to the present disclosure, shown when the sock is being worn by the patient over a bandaged foot. - Certain implementations of an expansion sock according to this disclosure are shown in
FIGS. 1-6 herein. Referring toFIG. 1 , anexpansion sock 21 is shown being worn by a patient on a bandaged foot a, including leg b. The sock may have acalf portion 23 configured and sized to expand circumferentially around a corresponding calf of a leg b of the patient having bandaged foot a.Calf portion 23 extends toward the foot a of the patient and terminates in abottom edge 25, whichbottom edge 25 is located so that, when thesock 21 is worn by the patient, thebottom edge 25 is proximate to, but above, malleoli c. - A
foot portion 27 has atop edge 29 extending frombottom edge 25 and is sized and shape to circumferentially enclose bandaged foot a of the patient. As described in further detail below,foot portion 27 includes one or more expansion zones 43, which include areas of knitted fabric in which the knitted fabric is more expandable than that ofcalf portion 23. By “more expandable” it is meant thatfoot portion 27 is able to stretch where necessary to accommodate the larger profile or volume caused by a bandage which extends away from the normal outer surface of the foot, and such expansion is accomplished without significantly increasing the compressive force felt by the foot, and in a way that does not cause excessive bunching of fabric in non-expanded, adjacent areas ofsuch foot portion 27. Accordingly, in the example illustrated inFIG. 1 , the increase in profile or volume to an otherwise normal foot is in the form of a bulge caused by a bandage over the great toe d. The areas offoot portion 27 overlying the bulge have expanded to accommodate such bulge without significantly increasing compressive force on such bulge beyond that otherwise felt in normal areas of the foot, and without causing excess material or bunching of material in non-bandaged areas as well. - Referring now to
FIGS. 2-4 , another possible implementation of an expansion sock according to this disclosure is shown and will be described hereinafter.Expansion sock 121 includescalf portion 123 sized and configured to fit over an unbandaged calf of a patient, andfoot portion 127 is configured to fit over a bandaged foot, theportions top edges -
Foot portion 127 may be conceptually divided into three sections, a heel-ankle section 131, amid-foot section 133, and aforefoot section 135. Heel-ankle section 131 is sized to cover at least the heel and extend above the malleoli c (FIG. 1 ).Forefoot section 135 has a closedend 137 and is located and dimensioned to cover metatarsal heads and toes of the patient's foot, andmid-foot section 133 extends between heel-ankle andforefoot sections - In one possible implementation, the expansion sock consists essentially of knitted fabric, with the word “knitted” intended to encompass any number of natural, synthetic, polymeric, rubberized, elastic, or other types of fabric, whether knitted in the conventional sense of having a woven pattern, or knitted in the sense of being imprinted or formed so as to be capable of varying in dimension or orientation in response to force
-
Calf portion 123, in one suitable implementation, may consist essentially of a first type of the knittedfabric 190. Thisfabric 190 is selected so as to have the normal feel and comfort of a sock worn on the unbandaged calf of the patient. In such case, the knittedfabric 190 may be characterized by a corresponding force at specified elongation (FASE) at 100% to accomplish such normal fit. Although those skilled in the art may define compression, comfort and fit in slightly different ways, one suitable metric used in therapeutic circles is to express sock fit is in terms of compressive force measured in mmHg. Compressive forces of less than 15 or 20 mmHg have been considered as being normal comfort or non-medical compression suitable for wearing under normal circumstances over a normal unbandaged calf, as contemplated by the present disclosure. In other possible implementations, there are other alternative ways to referencing compressive force, in which it is appropriate to express normal sock fit as a percentage of expansion from its relaxed state. According to such, those skilled in the art may consider that expansion to no more than 15% of the relaxed volume is a suitable design for a knitted sock to “fit.” - In terms of Force at Specified Elongation, various testing methods for yarns of may be employed in the selection of fabrics for calf and foot portions. One suitable testing method is set out in ASTM D2731-15, “Standard Test Method for Elastic Properties of Elastomeric yarns (CRE Type Tensile Testing Machines).”
- While the
calf portion knitted fabric 190 are configured to expand by amounts within the normal range and exert normal compression suitable to keep a sock up on a calf,foot portion 127 includes one or more portions or areas having knittedfabric 199 which defines one ormore expansion zones 143 capable of expanding more readily than the knittedfabric 190 ofcalf portion Expansion zones 143 are capable of expanding to accommodate the increased bulk of a bandage on the foot, without either causing excess compressive force on the bandage and thereby causing discomfort or further injury, and also without having excess material susceptible to bunching or folding, which likewise might abrade or otherwise cause blistering or other discomforts to the foot. In the implementation illustrated inFIGS. 2-4 , at least one of or more of heel-ankle section 131,mid-foot section 133, andforefoot section 135 may consist essentially of a more expandable, second type of knitted fabric and define one or morecorresponding expansion zones 143 thereby. In the example illustrated inFIGS. 2-4 , all three ofsections entire foot portion 127, are formed out of the more expandable fabric, and define a singlecontinuous expansion zone 143.Discontinuous expansion zones 143, occupying all or portions ofsections - When the
knitted fabric 199 of expansion zone orzones 143 is described herein as being different from thefabric 190 of the calf portion, or being “a second type” of fabric, it will be appreciated by those skilled in the art that such descriptions refer to the different properties ofsuch fabric 199, as compared tofabric 190 incalf portion 123. Thus, for example, the more expandable properties of knittedfabric 199 in expansion zone(s) 143, as opposed to that incalf portion fabric 199 are thinner (have a lower denier), or have looser or different weaves, or are treated, combined with, or alternated with polymeric or other types of fibers.Fabric 199 inexpansion zones 143 may likewise be considered different, or of second type, compared to that in calf portions in the sense of being formed of fibers of a different material, fiber, or of a non-woven but flexible material. - In its relaxed (unworn) state, as seen in
FIGS. 2-4 , thesock 121 and its knitted fabric may be thought of as enclosing afirst volume 139 by means ofcalf portion 123, and asecond volume 141 by means of knitted fabric infoot portion 127. Although any number of knitted fabrics may be suitable to provide the additional expansion contemplated herein, one suitable implementation has afoot portion 127 with an FASE at 100% which is less than the FASE at 100% of thecalf portion 123,such foot portion 127 being configured to generate a compressive force less than 20 mmHg whenexpansion zone 143 is expanded beyond 15% of second (relaxed state)volume 141. In other implementations, the knitted fabric ofexpansion zone 143 may be configured so that the compressive force remains less than 20 mmHg whenexpansion zone 143 is expanded to any volume in the range of between 50% and 200% of the relaxed state ofsecond volume 141 of the foot portion. - In still further implementations, only one or two sections of 131, 133 and 135 are configured with the more expandable fabric. Such implementations may be more suitable when the
expansion sock 121 is contemplated for use with foot injuries located in one of thosesections FIGS. 2-4 . The more expandable areas of knitted fabric defining correspondingexpansion zones 43, 143 may extend completely about the foot circumference ofsections sections foot portion 127 in which a bandage may need to be accommodated. -
Forefoot section 135 defines an expansion zone extending circumferentially around the forefoot and thereby overlies the top of bandaged foot a (FIG. 1 ), as well as the upper and lower surfaces and sides of the toes, when worn by the patient. Still further variations may be contemplated in terms of the location of more expandable types of fabric relative to portions of the foot within theexpansion sock fabric 199 offoot portion 127 may include anupper area 145 sized and located to underlie the upper surface of bandaged foot a, whereas the opposite, lower, plantar section offoot portion 127 is formed of another, less expandable type of fabric, such asfabric 190. - In those embodiments where only portions of
foot portion 127 comprise the more expandable,knitted fabric 199, the increased expandability may be determined or expressed in any suitable manner. For example,fabric 199 may have an FASE at 100%, 200% or other suitable tensile test percentage which is less than the comparable FASE offabric 190 at adjacent areas offoot portion 127 made of the first type of (less expandable) fabric. The expansion zones in such embodiments may likewise be expressed as allowing expansion beyond 15%, or between 50% and 200%, or between 75% and 300%, while not increasing the compressive force beyond 50% of the compressive force of “normal fit.” The expansion percentages of this disclosure, such as beyond 15%, between 50% and 200%, and between 75% and 300%, are determinable, in one possible implementation, by base reference to the surface area of the second type of knitted fabric when in its relaxed state. Alternatively, expansion of an area of the second type of knitted fabric may be measured with base reference to a sock volume corresponding to the expansion area. - Given the tubular or cylindrical nature of socks in general, expansion socks according this disclosure may have
expansion zones 143 located on areas of thefoot portion 127 which may not directly overlie or align with the bandaged portions of the foot, but which zones may nonetheless expand as described to allow displacement of the fabric overlying the bandage within the volume parameters described herein. For example, such implementation may have an expandable area at one longitudinal location along the length of the socks, located adjacent the plantar surface of a foot inserted therein. As such, if bandaging is located at the same longitudinal location along the length of the sock, but on the upper surface of the foot rather than the plantar surface, then the expansion zone on the plantar surface will expand in area, permitting the fabric adjacent to the upper to be displaced by the bandage, the resulting net expansion of volume or expansion zone area of such location exceeding 15% from its relaxed state, while not significantly increasing compression on such bandage. - Referring now more particularly to
FIGS. 5-6 , another possible implementation of the disclosure includesexpansion sock 221, which makes use of the more expandable type of knittedfabric 299 in heel-ankle section 231 andforefoot section 235, to form correspondingexpansion zones 243. The other portions of the sock are as described with reference to the embodiment ofFIGS. 2-4 with the exception ofmid-foot section 233, which is formed of less expandable knittedfabric 290 adapted to fit unbandaged portions of the patient's foot. As shown inFIGS. 5-6 , the injury at the big toe has been accommodated by expansion of knitted fabric inforefoot section 235 beyond 15% of its relaxed volume and without increasing compressive force beyond 20 mmHg. - In addition to the features described above with reference to
expansion sock FIGS. 2-4 ) may include padded material orfabric 147, and similarpadded material 147 may be provided in heel-ankle section 131 andforefoot section 135. - In certain implementations, it is desirable to provide padding in the
expansion sock calf portion 123 may include aforward calf portion 149 sized and configured to include padded material overlying the antibial crest when worn by the patient. - Certain foot disorders and conditions, such as ulcers, wounds, and other foot injuries, can be found in diabetics, and these and other patients may benefit from still further material properties being included in expansion socks in this disclosure. Thus, for example, knitted material in
foot portion 127 may comprise antimicrobial material, low friction material, heat retaining material, heat resisting material, insulating material, and wicking material. Alone or in in any combination, such materials may assist in healing of the foot injury and avoiding complications of infection or other undesirable delays in recovering or convalescence. With regard to antimicrobial material, suitable properties may include active ingredients that kill or otherwise reduce the spread of bacteria, fungus, yeasts, or viruses. Examples include, but are not limited to, PTFE, silver, zinc, phenolic compounds, copper metals, heavy metals, QAC, QUAT (ammonium compounds), hydrophilic coatings, polymers, biocides, fungicides, antivirals, and any compositions, materials, or treatments that inhibit growth, attachment, or attraction of bacteria, fungus, yeasts, or viruses. - Low friction sock materials may be used in
expansion sock 21 and have properties that reduce the coefficient of friction between any or all of the foot andsock 21 relative to each other; thesock 21 and the adjacent device, floor, ground or other support surface; and, ultimately, the foot relative to such support surfaces (wheresock 21 is intermediate or serves as a contact layer between the two). Low-friction materials suitable forsock 21 may include PTFE, nylon, TEFLON, polyesters, LYCRA, SPANDEX, silicone, rayon, wool, bamboo, and multiple layers of these or other fabrics. - Sock materials may be used in
expansion sock 21 that insulate the foot received therein from being either to hot or too cold, and/or which minimize accumulation of perspiration through wicking. Such materials include, without limitation, polyester, wools, microencapsulated phase change materials (PCMs), polyurethanes, and a variety of technical fabrics. Materials and fabrics may also provide the foregoing properties by virtue of weave density (denier), material infusion, blending, coating, spinning of one fabric over a core of another fabric, and technical fabrics with any and all of the foregoing customized to meet requirements related to insulation and wicking. - Although
expansion sock 21 has been illustrated with reference to a particular immobilizing device, it would be appreciated that expansion socks according to the present disclosure may serve as a contact layer between the bandaged foot received in or retained by any number of other healing environments, such as with an overlying cast, splint, or other immobilizing devices; the expansion socks of the present disclosure may likewise be used in CAM walkers, boots, or similar limb orthopedic devices, or may be worn in therapeutic or regular footwear. - In addition to the broadly declined knitted fabrics suitable for the expansion socks of the present disclosure, still further expansion sock implementations may comprise knitted. material on either one layer, or may use multiple layers of knitted fabric of the same or differing properties, material, denier, thread-types and the like.
- Having described the features of the expansion sock in the present disclosure, its advantages will be readily apparent. The bandaged foot of a patient may be enclosed with all its attendant advantages of substantially isolating it from further contaminants and undesirable elements, while minimizing the discomfort which might be associated with excessive pressure on the bandage portion of the foot, as well as the discomfort resulting from ill-fitting material at or adjacent to the bandaged portion of the foot.
- Having described implementations of the expansion sock herein, it will be appreciated that this disclosure is not limited to the precise details, methodologies, materials, or geometries set forth herein, nor is this disclosure limited to the illustrated implementations or variations thereof described herein. Accordingly, still further variations and implementations are within the spirit and scope of this disclosure.
Claims (14)
1. An expansion sock for use with a bandaged forefoot of a patient, the sock comprising:
a calf portion configured and sized to expand circumferentially around a leg of the patient having the bandaged foot, the calf portion extending from a top edge proximate to the calf of the patient toward the foot of the patient and adapted to terminate in a bottom edge located above the malleoli when the sock is worn by the patient;
a foot portion having a top edge extending from the bottom edge of the calf portion;
wherein the foot portion, when worn by the patient, is sized and shaped to circumferentially enclose the foot of the patient;
wherein the foot portion includes a heel-ankle section, a midfoot section, and a forefoot section, the heel-ankle section sized to cover at least the heel and both of the malleoli, the forefoot section having a closed end located and dimensioned to cover the metatarsal heads and the toes, and the midfoot section located and extending between the heel-ankle section and the forefoot section;
wherein the sock consists essentially of knitted fabric enclosing a first volume in the calf portion and a second volume in the foot portion when the sock is in an unworn, relaxed state;
wherein the calf portion, the heel-ankle section, and the midfoot section consist essentially of a first type of the knitted fabric, the first type of the knitted fabric characterized by a first force at specified elongation (FASE) at 100% selected and configured to generate a first compressive force less than 20 mmHg when any one of the calf portion, the heel-ankle section, and the midfoot section is expanded to 15% of the first volume of the relaxed state, whereby, when the sock is worn, the calf portion fits the leg and the heel-ankle section and midfoot section fit the heel-ankle and midfoot, respectively; and
an expansion zone located in the forefoot section a n d consisting essentially of a second type of knitted fabric configured to maintain a second compressive force that neither equals nor exceeds 20 mmHg of compression at any expansion of the expansion zone beyond 15% and up to 200% of the second volume, whereby, when the sock is worn over bandaged forefoot, the forefoot portion does not exert compressive force beyond normal sock fit.
2. The sock of claim 1 , wherein the second type of knitted fabric is selected to generate the less than 20 mmHg compressive force when the expansion zone is expanded to any volume in the range of between 50% and 200% of the relaxed state.
3. The sock of claim 1 , wherein the forefoot section is adapted to extend circumferentially around the forefoot to overlie the top of the foot above the metatarsal heads, and upper and lower surfaces and sides of the toes, when worn by the patient.
4. The sock of claim 1 , wherein the calf portion includes an upper calf portion located at the top edge of the calf portion, and wherein the knitted fabric of at least one of the upper calf portion, the heel-ankle portion, and the forefoot portion further comprises padded fabric.
5. The sock of claim 1 , wherein the calf portion includes an upper calf portion located at the top edge of the calf portion, wherein the calf portion comprises a forward calf portion comprising padded fabric and extending longitudinally and substantially from the upper calf portion to the bottom edge of the calf portion, and wherein the forward calf portion has a transverse width and is located on the circumference of the calf portion to overlie the antibial crest when worn by the patient.
6. The sock of claim 1 , wherein at least one of the first and second compressive forces generated by the first and second types of fabric, respectively, is 15 mm HG or less.
7. The sock of claim 1 , wherein the knitted fabric comprises at least one material selected from the group consisting of (1) antimicrobial material; (2) machine-washable material;
(3) multilayer material; (4) low-friction material; (5) heat-retaining material; (6) heat-resisting material; (7) insulating material; and (8) wicking material.
8. An expansion sock for use with a bandaged foot of a patient, the sock comprising:
a calf portion configured and sized to expand circumferentially around a leg of the patient having the bandaged foot, the calf portion extending from a top edge proximate to the calf of the patient toward the foot of the patient and adapted to terminate in a bottom edge located above the malleoli when the sock is worn by the patient;
a foot portion having a top edge extending from the bottom edge of the calf portion;
wherein the foot portion, when worn by the patient, is sized and shaped to circumferentially enclose the foot of the patient;
wherein the foot portion includes a heel-ankle section, a midfoot section, and a forefoot section, the heel-ankle section sized to cover at least the heel and both of the malleoli, the forefoot section having a closed end located and dimensioned to cover the metatarsal heads and the toes, and the midfoot section located and extending between the heel-ankle section and the forefoot section;
wherein the sock consists essentially of knitted fabric enclosing a first volume in the calf portion and a second volume in the foot portion when the sock is in an unworn, relaxed state;
wherein the calf portion, the heel-ankle section, and the midfoot section consist essentially of a first type of the knitted fabric, the first type of the knitted fabric characterized by a first force at specified elongation (FASE) at 100% selected and configured to generate a first compressive force less than 20 mmHg when any of the calf portion, the heel-ankle section, or the midfoot section, is expanded to 15% of the first volume of the relaxed state, whereby, when the sock is worn, the calf portion fits the leg and the heel-ankle section and midfoot section fit the heel-ankle and midfoot, respectively;
an expansion zone located in the forefoot section and consisting essentially of a second type of knitted fabric configured to maintain a second compressive force that neither equals nor exceeds 20 mmHg of compression at any expansion of the expansion zone beyond 15% and up to 200% of the second volume, whereby, when the sock is worn over the bandaged forefoot, the forefoot portion does not exert compressive force beyond normal sock fit;
wherein the forefoot section is adapted to extend circumferentially around the forefoot to overlie the top of the foot above the metatarsal heads, and upper and lower surfaces and sides of the toes, when worn by the patient;
wherein the calf portion includes an upper calf portion located at the top edge of the calf portion, and wherein the knitted fabric of at least one of the upper calf portion, the heel-ankle portion, and the forefoot portion further comprises padded fabric;
wherein the calf portion comprises a forward calf portion comprising padded fabric and extending longitudinally and substantially from the upper calf portion to the bottom edge of the calf portion, and wherein the forward calf portion has a transverse width and is located on the circumference of the calf portion to overlie the antibial crest when worn by the patient; and
wherein the knitted fabric of the foot portion comprises at least one material selected from the group consisting of an anti-microbial material, a low-friction material, an insulating material, and a wicking material.
9. The sock of claim 8 , wherein the knitted fabric of the foot portion includes a plantar area sized and located to underlie the plantar surface of the foot and incorporating all of the sock materials.
10. The sock of claim 8 , wherein at least one of the first and second compressive forces generated by the first and second types of fabric, respectively, is 15 mmHg or less.
11. The sock of claim 8 , wherein the knitted fabric of the foot portion comprises the at least one anti-microbial material, the material having at least one composition selected from the group consisting of PTFE, silver, phenolic compounds, copper metals, heavy metals, QAC, ammonium compounds, hydrophilic coatings, polymers, biocides, fungicides, antiviral compounds.
12. The sock of claim 8 , wherein the knitted fabric of the foot portion comprises the at least one low-friction material, the low-friction material selected from the group consisting of PTFE, nylon, TEFLON, polyesters, LYCRA, SPANDEX, silicone, rayon, wool, and bamboo.
13. The sock of claim 8 , wherein the knitted fabric of the foot portion comprises the at least one insulating material, the insulating material selected from the group consisting of polyester, wools, microencapsulated phase change materials (PCMs), polyurethanes, and technical fabric.
14. The sock of claim 8 , wherein the knitted fabric of the foot portion comprises the at least one wicking material, the wicking material selected from the group consisting of polyester, wools, microencapsulated phase change materials (PCMs), polyurethanes, and technical fabric.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/969,353 US20230047698A1 (en) | 2017-11-22 | 2022-10-19 | Expansion sock |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/821,273 US20190150523A1 (en) | 2017-11-22 | 2017-11-22 | Expansion Sock |
US17/066,437 US20210106070A1 (en) | 2017-11-22 | 2020-10-08 | Expansion sock |
US17/969,353 US20230047698A1 (en) | 2017-11-22 | 2022-10-19 | Expansion sock |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/066,437 Continuation US20210106070A1 (en) | 2017-11-22 | 2020-10-08 | Expansion sock |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230047698A1 true US20230047698A1 (en) | 2023-02-16 |
Family
ID=66534307
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/821,273 Abandoned US20190150523A1 (en) | 2017-11-22 | 2017-11-22 | Expansion Sock |
US17/066,437 Abandoned US20210106070A1 (en) | 2017-11-22 | 2020-10-08 | Expansion sock |
US17/969,353 Pending US20230047698A1 (en) | 2017-11-22 | 2022-10-19 | Expansion sock |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/821,273 Abandoned US20190150523A1 (en) | 2017-11-22 | 2017-11-22 | Expansion Sock |
US17/066,437 Abandoned US20210106070A1 (en) | 2017-11-22 | 2020-10-08 | Expansion sock |
Country Status (2)
Country | Link |
---|---|
US (3) | US20190150523A1 (en) |
WO (1) | WO2019103786A1 (en) |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649910A (en) * | 1985-05-31 | 1987-03-17 | Meridian Industries Inc. | Orthopedic stocking |
US5319807A (en) * | 1993-05-25 | 1994-06-14 | Brier Daniel L | Moisture-management sock and shoe for creating a moisture managing environment for the feet |
US5724836A (en) * | 1996-07-16 | 1998-03-10 | Sara Lee Corporation | Sock with breathable panel |
FR2813523B1 (en) * | 2000-09-04 | 2003-03-07 | Innothera Topic Int | COMPRESSIVE TUBULAR ORTHESIS FOR THE SUPPORT OF A LOWER LIMB AFTER VENOUS SURGERY, PARTICULARLY AFTER VEIN OR AMBULATORY PHLEBECTOMY |
US20020115955A1 (en) * | 2001-02-16 | 2002-08-22 | Desena Danforth | Surgical sock |
US8663144B2 (en) * | 2004-03-22 | 2014-03-04 | Farrow Medical Innovations Holdings Llc | Modular compression device and method of assembly |
US7007517B2 (en) * | 2004-08-02 | 2006-03-07 | Menzies—Southern Hosiery Mills, Inc. | Knit sock |
US20060085894A1 (en) * | 2004-10-26 | 2006-04-27 | Bsn-Jobst, Inc. | Compression garment with integral donning aid |
US7441419B1 (en) * | 2005-10-07 | 2008-10-28 | Carolon Company | Therapeutic compression and cushion sock and method of making |
US20070135749A1 (en) * | 2005-12-08 | 2007-06-14 | Williams Emmanuel R | Response of lower-leg extremities |
US20070283483A1 (en) * | 2006-03-23 | 2007-12-13 | Jacober Alan M | Therapeutic sock for diabetics |
JP5102611B2 (en) * | 2007-12-27 | 2012-12-19 | 岡本株式会社 | socks |
EP2329731B1 (en) * | 2009-12-07 | 2013-04-24 | NoCut I Sverige AB | Cut resistant sports sock |
WO2011143489A2 (en) * | 2010-05-13 | 2011-11-17 | Vazales Brad E | Variable compression stockings |
FR2964034B1 (en) * | 2010-08-30 | 2012-09-28 | Tournier Bottu Internat | ORTHESIS OF COMPRESSION |
WO2013106410A2 (en) * | 2012-01-10 | 2013-07-18 | Duda Marcus | Improved sock for treatment of foot and leg wounds, methods of use and manufacture |
US20150157524A1 (en) * | 2013-12-06 | 2015-06-11 | Lawrence G. Reid, Jr. | Sleeve-Wrap Compression System and Method |
US10034497B1 (en) * | 2015-07-08 | 2018-07-31 | Rhonda G. Jackson | Infant/toddler sock system |
US20170258641A1 (en) * | 2016-03-10 | 2017-09-14 | Celeste Stein | Decorative Graduated Compression sock |
-
2017
- 2017-11-22 US US15/821,273 patent/US20190150523A1/en not_active Abandoned
-
2018
- 2018-09-27 WO PCT/US2018/053160 patent/WO2019103786A1/en active Application Filing
-
2020
- 2020-10-08 US US17/066,437 patent/US20210106070A1/en not_active Abandoned
-
2022
- 2022-10-19 US US17/969,353 patent/US20230047698A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210106070A1 (en) | 2021-04-15 |
US20190150523A1 (en) | 2019-05-23 |
WO2019103786A1 (en) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4763045B2 (en) | Compressible tightening brace for lower limbs in the form of knitting in stockings, socks, or tights | |
US5617745A (en) | Support sock | |
AU2018203961B2 (en) | Fabrics, compression garments and compression garment systems | |
US10456287B2 (en) | Therapeutic sock | |
US10039663B2 (en) | System and methods for applying a total contact and offloading cast | |
US8491514B2 (en) | Customizable therapeutic compression garment and method | |
EP2526793B1 (en) | Foot joint supporter | |
EP2323603A1 (en) | Therapeutic compression garments | |
US20230122424A1 (en) | Non-water-activated cast | |
US20110061664A1 (en) | Stocking for feet with bunions | |
KR20010052324A (en) | Compression bandage | |
EP1246591A1 (en) | Sock or stocking for therapeutic use | |
US20230047698A1 (en) | Expansion sock | |
US20170175310A1 (en) | Fabrics, compression garments and compression garment systems | |
Finnie | Bandages and bandaging techniques for compression therapy | |
EP3662877A1 (en) | heel protector | |
JP6985653B2 (en) | Elastic stockings |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HEEL-IT, LLC, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HANFT, JASON R.;REEL/FRAME:061472/0711 Effective date: 20171122 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |